SCN7A
MOLECULAR TARGETsodium voltage-gated channel alpha subunit 7
SCN7A (sodium voltage-gated channel alpha subunit 7) is targeted by 8 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting SCN7A
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | tetrodotoxin | 3.14 | 22 |
| 2 | pf 05089771 | 2.40 | 10 |
| 3 | Saxitoxin | 0.69 | 1 |
| 4 | bdb chembl5082739 | 0.69 | 1 |
| 5 | bdb us8952169 148 us9771376 example 148 | 0.69 | 1 |
| 6 | bdb us8952169 154 | 0.69 | 1 |
| 7 | bdb us8952169 155 | 0.69 | 1 |
| 8 | bdb us8952169 60 us9771376 example 60 | 0.69 | 1 |
About SCN7A as a Drug Target
SCN7A (sodium voltage-gated channel alpha subunit 7) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 8 compounds with documented SCN7A interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
SCN7A inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.